You are here

Clinical Trials: Bone Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: 08/02/2019 - 12:00
Condition:   Chronic Lumbar Disc Disease (cLDD)
Intervention:   Biological: BRTX-100
Sponsor:   BioRestorative Therapies
Not yet recruiting
Posted: 05/20/2019 - 12:00
Condition:   Degenerative Disc Disease
Interventions:   Biological: IDCT;   Procedure: Sham
Sponsor:   DiscGenics, Inc.
Not yet recruiting
Posted: 03/25/2019 - 12:00
Conditions:   Type 2 Diabetes Mellittus;   Hypogonadism
Interventions:   Drug: Testosterone gel 1.62%;   Drug: Placebo
Sponsor:   VA Office of Research and Development
Not yet recruiting
Posted: 03/18/2019 - 12:00
Conditions:   Growth Hormone Deficiency;   Growth Hormone Treatment
Intervention:   Drug: Genotropin miniquick 0.5 mg, injection
Sponsors:   University of Aarhus;   Aarhus University Hospital
Not yet recruiting
Posted: 12/14/2018 - 12:00
Conditions:   Heart Failure;   Growth Hormone Deficiency
Interventions:   Drug: Human growth hormone;   Other: Placebo
Sponsor:   Federico II University
Not yet recruiting
Posted: 10/16/2018 - 12:00
Condition:   Osteogenesis Imperfecta
Intervention:   Biological: BOOST cells
Sponsor:   Cecilia Götherström
Not yet recruiting
Posted: 01/29/2018 - 12:00
Condition:   Degenerative Scoliosis
Interventions:   Behavioral: Physiotherapeutic Scoliosis Specific Exercises (PSSE);   Behavioral: Conventional Physical Therapy (PT)
Sponsor:   Columbia University
Not yet recruiting
Posted: 01/04/2018 - 12:00
Conditions:   Osteoarthritis;   Tendinitis;   Sports Injury;   Degenerative Disc Disease;   Degenerative Arthritis;   Ligament Injury;   Neuropathy;   Pelvic Pain
Intervention:   Biological: Amniotic
Sponsor:   R3 Stem Cell
Recruiting
Posted: 11/20/2017 - 12:00
Condition:   Degenerative Disc Disease
Interventions:   Biological: IDCT;   Drug: Saline Solution;   Drug: Sodium Hyaluronate
Sponsor:   DiscGenics, Inc.
Not yet recruiting
Posted: 06/06/2017 - 12:00
Condition:   Osteonecrosis of Femoral Head
Interventions:   Drug: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#);   Procedure: core decompression
Sponsor:   Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified May 2017

Pages